Cardiovascular Disease Prevention: Prevention Through Control of Medical Risks

Brian V Reamy1, Anthony J Viera2

  • 1Department of Family Medicine - Uniformed Services University School of the Health Sciences School of Medicine, 4301 Jones Bridge Rd, Bethesda, MD 20814.

FP Essentials
|September 7, 2022
PubMed

Insights

Controlling diabetes, hypertension, smoking, and obesity is crucial for preventing cardiovascular disease (CVD). Individualized treatment goals balance risk reduction with potential adverse effects for better patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Cardiovascular disease (CVD) risk is significantly increased by diabetes, hypertension, tobacco use, and obesity.
  • Effective CVD prevention requires diligent management of these risk factors.
  • Social determinants of health play a primary role in disparities in CVD outcomes across racial and ethnic groups.

Purpose of the Study:

  • To outline current recommendations for managing key risk factors for cardiovascular disease.
  • To emphasize the importance of individualized treatment goals in CVD prevention.
  • To highlight the most effective interventions for smoking cessation and obesity management.

Main Methods:

  • Review of guidelines from organizations like the American Diabetes Association (ADA).
  • Analysis of evidence supporting specific A1c and blood pressure (BP) targets.
  • Evaluation of pharmacotherapy and surgical interventions for smoking cessation and weight management.

Main Results:

  • ADA recommends an A1c goal of <7% for most adults with diabetes, balancing efficacy with hypoglycemia risk.
  • A BP goal of <140/90 mm Hg is advised for adults, with individualized targets considering benefits and risks.
  • Varenicline combined with nicotine replacement therapy is highly effective for smoking cessation; bariatric surgery is optimal for obesity management.

Conclusions:

  • Optimizing management of diabetes, hypertension, smoking, and obesity is essential for cardiovascular disease prevention.
  • Individualized treatment targets for A1c and BP are necessary to maximize benefits and minimize risks.
  • Addressing social determinants of health is critical for reducing CVD outcome disparities.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.1K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.0K